{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T10:33:18Z","timestamp":1725877998229},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.jpeds.2009.04.065","type":"journal-article","created":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T12:08:34Z","timestamp":1251979714000},"page":"308-309","source":"Crossref","is-referenced-by-count":3,"title":["Pramlintide in Pediatric Type 1 Diabetes"],"prefix":"10.1016","volume":"155","author":[{"given":"Ilene","family":"Fennoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2009.04.065_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2009.04.065_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1067\/mpd.2001.118887","article-title":"Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)","volume":"139","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2009.04.065_bib3","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2337\/diacare.27.7.1554","article-title":"A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine","volume":"27","author":"Doyle","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2009.04.065_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1464-5491.2007.02311.x","article-title":"Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years","volume":"25","author":"Jakisch","year":"2008","journal-title":"Diabetes Med"},{"key":"10.1016\/j.jpeds.2009.04.065_bib5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","article-title":"Continuous glucose monitoring and intensive treatment of type 1 diabetes","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.jpeds.2009.04.065_bib6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S9::AID-DIA397>3.3.CO;2-4","article-title":"Amylin: history and overview","volume":"14","author":"Ludvik","year":"1997","journal-title":"Diabetes Med"},{"key":"10.1016\/j.jpeds.2009.04.065_bib7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diabetes.54.4.1100","article-title":"The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes","volume":"54","author":"Heptulla","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jpeds.2009.04.065_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00404025","article-title":"Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans","volume":"34","author":"Hartter","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpeds.2009.04.065_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","article-title":"Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin","volume":"38","author":"Young","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpeds.2009.04.065_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF01925572","article-title":"Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat","volume":"52","author":"Clementi","year":"1996","journal-title":"Experientia"},{"key":"10.1016\/j.jpeds.2009.04.065_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","article-title":"Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187","volume":"137","author":"Gedulin","year":"2006","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.jpeds.2009.04.065_bib12","series-title":"Amylin: physiology and pharmacology","first-page":"151","article-title":"Inhibition of Glucagon Secretion","author":"Young","year":"2005"},{"key":"10.1016\/j.jpeds.2009.04.065_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00060793-199708000-00006","article-title":"Amylin's physiology and its role in diabetes","volume":"4","author":"Young","year":"1997","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"10.1016\/j.jpeds.2009.04.065_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/diaclin.20.3.137","article-title":"Amylin replacement with pramlintide in type 1 and type 2 diabetes: a physiological approach to overcome barriers with insulin therapy","volume":"20","author":"Buse","year":"2002","journal-title":"Clin Diabet"},{"key":"10.1016\/j.jpeds.2009.04.065_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/VHRM.S1978","article-title":"Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk","volume":"4","author":"Hoogwerf","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jpeds.2009.04.065_bib16","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s001250050821","article-title":"Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations","volume":"40","author":"Thompson","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpeds.2009.04.065_bib17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diacare.25.4.724","article-title":"A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes","volume":"25","author":"Whitehouse","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2009.04.065_bib18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1203\/PDR.0b013e318159af8c","article-title":"The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes","volume":"62","author":"Rodriguez","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2009.04.065_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpeds.2009.03.012","article-title":"Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study","volume":"155","author":"Chase","year":"2009","journal-title":"J Pediatr"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347609004715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347609004715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T11:51:02Z","timestamp":1545047462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347609004715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0022347609004715"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2009.04.065","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}